Bleeding complications associated with dual antiplatelet therapy plus anticoagulant in patients who underwent percutaneous coronary intervention with drug-eluting stents

被引：0
|
作者：
Uchida, Yoshie [1 ]
Tsurumi, Yukio [1 ]
Takahashi, Atsushi [1 ]
Higasitani, Michiaki [1 ]
Kameyama, Kinichi [1 ]
Nagashima, Michitaka [1 ]
Mori, Furmaki [1 ]
Takagi, Atsushi [1 ]
Shiga, Tsuyoshi [1 ]
Hagiwara, Nobuhisa [1 ]
Kasanuki, Hiroshi [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3474
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [31] Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
    Shen Ying
    Shen Wei-Feng
    中华医学杂志英文版, 2015, 128 (06) : 711 - 713
  • [32] Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
    Shen, Ying
    Shen, Wei-Feng
    CHINESE MEDICAL JOURNAL, 2015, 128 (06) : 711 - 713
  • [33] Duration of dual antiplatelet therapy following drug-eluting coronary stents: Longer or shorter?
    Fan, Zhixing
    Yang, Jian
    Yang, Chaojun
    Yang, Jun
    Zeng, Ping
    Guo, Xin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 936 - 937
  • [34] Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention Insight From the STOPDAPT-2 Trial
    Yamamoto, Ko
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Domei, Takenori
    Ohya, Masanobu
    Ogita, Manabu
    Takagi, Kensuke
    Suzuki, Hirohiko
    Nikaido, Akira
    Ishii, Mitsuru
    Fujii, Shinya
    Natsuaki, Masahiro
    Yasuda, Satoshi
    Kaneko, Takeo
    Tamura, Takashi
    Tamura, Toshihiro
    Abe, Mitsuru
    Kawai, Kazuya
    Nakao, Koichi
    Ando, Kenji
    Tanabe, Kengo
    Ikari, Yuji
    Hanaoka, Keiichi Igarashi
    Morino, Yoshihiro
    Kozuma, Ken
    Kadota, Kazushige
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (05) : 469 - 479
  • [35] Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents? All Patients With Drug-Eluting Stents Need at Least 12 Months of Dual Antiplatelet Therapy
    Brener, Sorin J.
    CIRCULATION, 2015, 131 (22) : 2001 - 2009
  • [36] Changes in the use of drug-eluting stents for percutaneous coronary intervention
    Nadar, S.
    Varma, C.
    Millane, T.
    Lip, G.
    Watson, R.
    HEART, 2008, 94 : A34 - A34
  • [37] Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents
    Matteau, Alexis
    Yeh, Robert W.
    Camenzind, Edoardo
    Steg, Gabriel P.
    Wijns, William
    Mills, Joseph
    Gershlick, Anthony
    de Belder, Mark
    Ducrocq, Gregory
    Mauri, Laura
    CIRCULATION, 2013, 128 (22)
  • [38] Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents
    Matteau, Alexis
    Yeh, Robert W.
    Camenzind, Edoardo
    Steg, P. Gabriel
    Wijns, William
    Mills, Joseph
    Gershlick, Anthony
    de Belder, Mark
    Ducrocq, Gregory
    Mauri, Laura
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05): : 686 - 693
  • [39] Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
    Chu, WW
    Kuchulakanti, PK
    Torguson, R
    Wang, B
    Clavijo, LC
    Suddath, WO
    Pichard, AD
    Satler, LF
    Kent, KM
    Waksman, R
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (04) : 595 - 599
  • [40] Dual Antiplatelet Therapy in Percutaneous Coronary Intervention A Tale of 2 Decades With New Perspectives in the Era of New-Generation Drug-Eluting Stents
    Piccolo, Raffaele
    Windecker, Stephan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (02)
12345